Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases.

about

Current Classification and Management of Inflammatory Myopathies.Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis.Assessment of renal function in patients with myositis and treated with subcutaneous immunoglobulin: a series of 24 cases

P2860

Q54977148-47AFE8E5-667F-416C-B9DB-7AF70B0FA065 Q55322436-1AB2A714-F14F-4A9C-AD0B-CCC5AEC97379 Q57482179-1552667F-120C-4411-9232-6E1A557BDB01

P2860

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases.

Item

http://www.wikidata.org/entity/Q38645740

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases.

@en

type

Item

label

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases.

@en

prefLabel

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases.

@en

P1476

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases.

@en

P2093

Christophe de Jaeger

http://www.w3.org/2001/XMLSchema#string

Jean-Charles Crave

http://www.w3.org/2001/XMLSchema#string

Jean-Christophe Delain

http://www.w3.org/2001/XMLSchema#string

Patrick Cherin

http://www.w3.org/2001/XMLSchema#string

P2860

A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM.

Sporadic inclusion body myositis: a continuing puzzle.

High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study.

Intravenous immunoglobulin for dysphagia of inclusion body myositis.

Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies.

Long-term observational study of sporadic inclusion body myositis.

Treatment of inflammatory myopathies.

Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients.

Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis.

Subcutaneous immunoglobulin treatment of inclusion-body myositis stabilizes dysphagia.

P304

227-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000441490

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283540388

http://www.w3.org/2001/XMLSchema#string

P698

26600787

http://www.w3.org/2001/XMLSchema#string

P932

4649754

http://www.w3.org/2001/XMLSchema#string

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases.

about

P2860

P2860

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932